Abstract: The invention relates to make-up remover composition using low oil and retaining excellent make-up removal efficiency. The composition foams well, rinses easily and has good phase stability when the correct balance of ingredients is selected.
FORM - 2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
MAKE-UP REMOVAL COMPOSITION WHICH PROVIDES GOOD FOAM
HINDUSTAN UNILEVER LIMITED, a company incorporated under
the Indian Companies Act, 1913 and having its registered office
at 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the invention and the manner in which it is to be performed
MAKE-UP REMOVAL COMPOSITION WHICH PROVIDES GOOD FOAM
FIELD OF THE INVENTION
The present invention relates to makeup removal compositions which also provide good foam,
BACKGROUND OF THE INVENTION
Make-up remover is typically applied to skin as a liquid oil composition and has littfe or no foam. It would be advantageous to find a make-up composition which uses [ess oi( and rinses off more easffy, but retains some make-up removing efficiency.
By utilizing specific foaming anionic surfactant, applicants can provide foaming make-up remover which uses less oil (e.g., hydrogenated polyisobutene) and rinses off more readily. To ensure the efficiency of make-up removal and stability of such composition, a specific combination of amphoteric (hydroxysultaine), nonionic and C10-C14 ester oil are also needed. It has been found that certain levels of specific nonionics, including at least 0.1% alkyl glucoside, are required to maintain the overall efficiency and stability.
Three references which display general knowledge, but not the specific combinations of the invention are:
(1) JP 2005-200640 to NOF Corporation;
(2) JP H09-175936 to Kao; and
(3) JP H06-016524to Kao
Additional references which display general knowledge but not the specific combinations of the invention are EP 0 687 721 and US 2005/180939.
EP 0 687 721 discloses a detergent composition containing an N-acylthreonine salt in combination with a higher fatty acid salt. The detergent composition exhibits little irritation and has improved foam maintenance, foam quality and feel upon use.
US 2005/180939 discloses a foaming skin cleansing composition comprising a physiologically acceptable medium, a surfactant system containing at least one anionic surfactant and at least one amphoteric surfactant. The composition also comprises a thickening system containing at least two different anionic polymers each comprising at least one hydrophobic chain.
BRIEF SUMMARY OF THE INVENTION
More specifically, the present invention comprises a foaming, easier to rinse make-up removing composition comprising:
(1) 1 to 10%, preferably 1.5 to 5% by wt. salt of N-alkoyl (e.g. N-acyf) amino acid, e.g., N-acyl glycinate; especially preferred is C-10-C16 alkali metal glycinate, e.g., acyl potassium glycinate;
(2) 1 to 10%, preferably 2 to 4% by wt. of an amphoteric surfactant comprising alkyl hydroxy sultaine;
(3) 0.1 to 10%, preferably 3 to 5% by wt. hydrogenated polyisobutene
(4) 0.1 to 10% by wt. nonionic surfactant selected from the group consisting of
alkyl glucoside and afkoxylated glyceryl, except that there is at least 0.1,
preferably at least 0.4% by wt. alkyl glucoside;
i (5) 0.1 to 5%, preferably 1 to 3% by wt. C10-C14 ester, preferably laurate ester
wherein preferably the ester {e.g., laurate ester) is free of hydroxyl functional group; and (6) balance water.
Compositions of the invention are preferably dispensed in a manner that the volume is about 5-20 times greater when dispensed relative to prior to dispensing. This is preferably accomplished using, for example a pump foamer dispenser package. Such package is beneficial, for example, for applying composition onto the face without dripping.
These and other aspects, features and advantages wifl become apparent to those of ordinary skill in the art from a reading of the following detailed description and the appended claims. For the avoidance of doubt, any feature of one aspect of the present invention may be utilized in any other aspect of the invention. It is noted that the examples given in the description below are intended to clarify the invention and are not intended to limit the invention to those examples per se. Similarly, all percentages are weight/weight percentages of the total composition unless otherwise Indicated. Numerical ranges expressed in the format "from x to y" are understood to include x and y. When for a specific feature multiple preferred ranges are described in the format from x to y", it is understood that all ranges combining the different endpoints are also contemplated. Where the term "comprising" is used in the specification or claims, it is not intended to exclude any terms, steps or features not specifically recited. All temperatures are in degrees Celsius (°C) unless specified otherwise. All measurements are in SI units unless specified otherwise. All documents cited are - in relevant part - incorporated herein by reference.
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides compositions that achieve make-up removal efficiency (MUR efficiency), while also providing good foaming (which actually helps with make-up removal efficiency), while using less oil. Moreover, all this is done while maintaining good stability of the compositions. This is accomplished through specific selection of compounds which interact with one another to maintain the delicately defined balance.
More specifically, good make-up removal efficiency Is obtained using combination of hydrogenated polyisobutene (oil) and alkyl hydroxy sultaine. Use of the hydroxysuJtaine permits the polyisobutene to be used at relatively low levels of 3 to 5% by wt Less oil is also used because of use of salts of N-alkoyl amino acid (e.g., N-afkyl gfycinate) as foaming anionic. Nevertheless, such systems are not stable unless there is also used, as a type of stabilization system, about 3 to 8% nonionic surfactant, where at least 1% of composition comprises alkyl glucoslde, in combination with 1 to 3% by wt of a C10- C14 ester oil, preferably laurate.
The composition is described in greater detail below.
Compositions of the invention comprise 1 to 10%, preferably 1.5 to 5% by wt. salts of N-alkoyl (N-acyl) amino acid represented by the following formula:
R'CONH{CHz)BCOOM
wherein R'CO is a straight chain acyl of C8 to C20, preferably C10 to C14 carbons
n ~ 1 or 2; and
M is alkali metal (e.g., sodium, potassium) or trialkanolamine.
An especially preferred compound is C10-C18 alkali metal gfycinates, e.g., acyf potassium glycinate.
The anionic is important because, in combination with hydroxysultaine, it aflows less oil (e.g., polyisobutene) to be used while still retaining good foaming. Stability of the oil, as discussed below, is further ensured through use of non ionic and ester oil stabilization system.
A second required component of the subject invention is amphoteric surfactant wherein said amphoteric comprises alkyl hydroxysultaine (e.g., lauryl hydroxysultaine). lt is believed that the amphoteric helps with cleanser efficiency while also helping with overall stability, principally provided by nonionic and ester combination.
The amphoteric is typically used in an amount of 1 to 10%, preferably 2 to 4% by wt. of the composition.
A third component of the compositions of the invention is hydrogenated polybutene. The hydrogenated polybutene oil, typically a good make-up remover, can be used in amounts of 0.1 to 5%, preferably 3 to 5% by wt. Higher amounts are not needed because, as noted, efficacy as provided by good foaming (as provided by N-acyl amino acid and hydroxysultaine) and combination of other ingredients. This permits also that the compositions have less greasy/oily feel than might be otherwise expected (e.g., according to consumer in-use testing).
Although less oil is used, stability is further provided through a combination of nonionic surfactant (which must comprise alkyl glucoside and/or alkoxylated glyceryl, except that there must be at least 0.1, preferably at least 0.4% alky! glucoside); and C10 C14 ester. The amphoteric also helps with stability.
Specifically, the compositions comprise 0.1 to 10% nonionic surfactant selected from the group consisting of alkyl glucoside and a/koxylated glyceryl except that at least 0.1 % wt alkyl glycoside must be present.
In addition, the composition must comprise 0.1 to 5%, preferably 1 to 3% by wt. C10-C14 ester, preferably a faurate ester. Preferably the ester (e.g., laurate ester} is free of hydroxy! functional groups.
The balance of the composition comprises water.
Compositions of the invention also may comprise other ingredients that may be used in make-up remover compositions. These include oils (e.g., ester oils, mineral oils and plant oils), silicone, fatty acids, alcohols, potyols, colorants, preservatives, perfumes, powders, scrubs, chelating agents, gelling agents and other ingredients such as may be well known to those skilled in the art of make-up removal formulations.
EXAMPLES
Protocol
Stability of compositions was measured by observing phase stability at ambient temperature (e.g., 20-25°C) after 24 hours. Compositions which did not phase separate were considered stable.
Make-up removal efficiency was defined by placing a dab of lipstick {about 0.0O8 g) on the arm (e.g., preferably the forearm). This is followed by applying the formula from a pump foamed package using a single push from the dispenser (dispensing about 12 cm3 formulation) and rubbing for about 60 seconds. The skin is then rinsed for about 30 seconds in water and a 5 point scale of visual assessment was used to determine removal.
Foam is measured by observing amount of foam released from pump foamer and grading based on 5 point visual scale.
Examples
The table below with Examples 1 and Comparatives A-M show how each element of the invention is needed to provide Ideal combination of MUR efficiency, foam, and phase stability. When some parameter or other is not met, there is typically some issue as noted in the description of the Comparatives,
Table 1
Ingredients E*. t
%hy
wt. A 8 C D e F G H 1 J K L M
Water 68.4 72.9 71.1 69.9 6B.B 71.9 71.4 69.75 72.9 69.9 73.3 83.4 68.4 68.4
Cocoyl glycmate 3 3 3 3 3 3 - 3 3 3 3 3 3 3
Lauryl
hydro xysultaine 2.7 2.7 - 2.7 2.7 2.7 2.7 1.35 2.7 2.7 2.7 2.7 h 2.7
Lauryl glucoside 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 - 0.4 0.4 0.4
PEG-20 glyceryl 4-5 4.5 4.5 4.5 4.S 4.5 4.6 4.5 - 4.5 - 4.5 4.5 4.5
Glycerin 4.5 4.5 4.5 4.5 4.5 4.5 4.S 4.5 4.5 4.5 4.5 - 4.5 4.5
Isopentyidiol 5 5 5 5 S 5 5 5 5 5 5 - 5 5
PEG-400 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 - 5.5 5.5
Laurate eater 1.5 1.5 1.5 - 1.5 1.5 1.5 1.5 1.5 - 1.5 1.5 1.5 **
hiydragenated jjojyisobutene 4.5 " 4,5 4.5 4.5 1 4.5 4.5 4.5 4.5 4.5 4.5 4.5
Stability OK OK OK Sep* Sep* OK OK OK Sep* Sep* Sep* OK OK Sep*
Appearance T T 0 T S O S S
MUR efficiency 5 1 4 3 2 2 3
Foam quickly 5
- No foam 5 5 2 5 5 5
Separates (i.e., phase separation) T = Transparent
Betaine used as amphoteric at 2,7% by wt. 0= Opaque
Isotridecyl tsononanoate was used as oil at 1.5% by wt. S = Semitransparent
What Comparatives Demonstrate:
A Shows you need oil (for foam formation),
B Shows you need hydroxysultaine for MUR efficiency,
C Shows you need ester for phase stability,
D Shows you also need nonionic (lauryl glucoside) for stability,
E Simitar to Example 1, but with only 1% polybutene, there is less optimal
MUR efficiency, F With no salt of N Acy) amino acid, there is big drop in both MUR efficiency
and foam;
G Shows that, without minimal sultaine, MUR efficiency is compromised;
H Shows that, w/o minimum nonionic, there is phase instability;
I Shows that ester oil is also required for stability;
J Again shows minimum nonionic needed for stability; K Suggests that a certain amount of polyol is required for optimal MUR
efficiencies, L With different amphoteric, less MUR efficiency; M With different oil, you get separation.
CLAIMS
1. A foaming, make-up remover composition comprising:
(a) 1-10% by wt. salts of N-acyi amino acid represented by the following
formula:
R'CONH(CH2)nCOOM,
wherein R' is straight chain acyl of C8-C20 carbons; n = 1 or 2 and M is
alkali metal salt ortrialkanolamine;
(b) 1-10% by wt. of an amphoteric surfactant comprising alkyl hydroxy sultaine;
(c) 0.1. to 10% by wt. hydrogenated polyisobutene;
(d) 0.1-10% nonionic surfactant selected from the group consisting of alkyl glucoside and alkoxylated glyceryl except that there must be at least 0.1% alkyl glucoside;
| # | Name | Date |
|---|---|---|
| 1 | 1904-MUMNP-2010-CORRESPONDENCE(IPO)-(28-12-2010).pdf | 2010-12-28 |
| 1 | 1904-MUMNP-2010-Form 3-210519.pdf | 2020-01-08 |
| 2 | 1904-MUMNP-2010-FORM 18(20-12-2011).pdf | 2011-12-20 |
| 2 | 1904-MUMNP-2010-Form 3-171219.pdf | 2019-12-20 |
| 3 | 1904-MUMNP-2010-Form 3-301118.pdf | 2019-11-08 |
| 3 | 1904-MUMNP-2010-CORRESPONDENCE(20-12-2011).pdf | 2011-12-20 |
| 4 | 1904-MUMNP-2010-FORM 3(10-12-2013).pdf | 2013-12-10 |
| 4 | 1904-MUMNP-2010-AbandonedLetter.pdf | 2018-10-31 |
| 5 | 1904-MUMNP-2010-Form 3-120618.pdf | 2018-09-27 |
| 5 | 1904-MUMNP-2010-FORM 3(10-11-2014).pdf | 2014-11-10 |
| 6 | 1904-MUMNP-2010-CORRESPONDENCE(IPO)-(FER)-(31-12-2014).pdf | 2014-12-31 |
| 6 | 1904-MUMNP-2010-CLAIMS(AMENDED)-(27-4-2015).pdf | 2018-08-10 |
| 7 | 1904-MUMNP-2010-FORM 3-(25-04-2015).pdf | 2015-04-25 |
| 7 | 1904-mumnp-2010-claims.pdf | 2018-08-10 |
| 8 | 1904-MUMNP-2010-CORRESPONDENCE(3-11-2010).pdf | 2018-08-10 |
| 8 | 1904-MUMNP-2010-CORRESPONDENCE(18-12-2015).pdf | 2015-12-18 |
| 9 | 1904-MUMNP-2010-CORRESPONDENCE(31-1-2013).pdf | 2018-08-10 |
| 9 | 1904-MUMNP-2010-FORM 3-(19-03-2016).pdf | 2016-03-19 |
| 10 | 1904-MUMNP-2010-Correspondence-010916.pdf | 2018-08-10 |
| 10 | Other Document [05-06-2017(online)].pdf | 2017-06-05 |
| 11 | 1904-MUMNP-2010-Correspondence-121015.pdf | 2018-08-10 |
| 11 | Form 26 [05-06-2017(online)].pdf | 2017-06-05 |
| 12 | 1904-MUMNP-2010-Correspondence-230215.pdf | 2018-08-10 |
| 12 | Form 13 [05-06-2017(online)].pdf | 2017-06-05 |
| 13 | 1904-MUMNP-2010-Correspondence-240615.pdf | 2018-08-10 |
| 13 | 1904-MUMNP-2010-ORIGINAL UNDER RULE 6(1A)-09-06-2017.pdf | 2017-06-09 |
| 14 | 1904-mumnp-2010-correspondence.pdf | 2018-08-10 |
| 14 | 1904-MUMNP-2010-Response to office action (Mandatory) [06-10-2017(online)].pdf | 2017-10-06 |
| 15 | 1904-mumnp-2010-description(complete).pdf | 2018-08-10 |
| 15 | 1904-MUMNP-2010-Proof of Right (MANDATORY) [27-11-2017(online)].pdf | 2017-11-27 |
| 16 | 1904-mumnp-2010-form 1.pdf | 2018-08-10 |
| 16 | 1904-MUMNP-2010-PETITION UNDER RULE 137 [27-11-2017(online)].pdf | 2017-11-27 |
| 17 | 1904-MUMNP-2010_EXAMREPORT.pdf | 2018-08-10 |
| 17 | 1904-MUMNP-2010-FORM 13(10-2-2012).pdf | 2018-08-10 |
| 18 | 1904-mumnp-2010-form 2(title page).pdf | 2018-08-10 |
| 18 | 1904-mumnp-2010-wo international publication report a3.pdf | 2018-08-10 |
| 19 | 1904-mumnp-2010-form 2.pdf | 2018-08-10 |
| 19 | 1904-mumnp-2010-wo international publication report a2.pdf | 2018-08-10 |
| 20 | 1904-MUMNP-2010-FORM 3(12-8-2011).pdf | 2018-08-10 |
| 20 | 1904-MUMNP-2010-REPLY TO EXAMINATION REPORT(27-4-2015).pdf | 2018-08-10 |
| 21 | 1904-MUMNP-2010-FORM 3(15-2-2011).pdf | 2018-08-10 |
| 21 | 1904-mumnp-2010-power of attorney.pdf | 2018-08-10 |
| 22 | 1904-MUMNP-2010-FORM 3(15-2-2012).pdf | 2018-08-10 |
| 22 | 1904-MUMNP-2010-OTHERS-240615.pdf | 2018-08-10 |
| 23 | 1904-MUMNP-2010-FORM 3(22-5-2014).pdf | 2018-08-10 |
| 23 | 1904-MUMNP-2010-OTHERS-230215.pdf | 2018-08-10 |
| 24 | 1904-MUMNP-2010-Original Under Rule 6(1 A)Form 3-250117.pdf | 2018-08-10 |
| 24 | 1904-MUMNP-2010-FORM 3(22-6-2013).pdf | 2018-08-10 |
| 25 | 1904-MUMNP-2010-FORM 3(23-1-2013).pdf | 2018-08-10 |
| 25 | 1904-MUMNP-2010-ORIGINAL UNDER RULE 6 (1A)-ASSIGNMENT-041217.pdf | 2018-08-10 |
| 26 | 1904-MUMNP-2010-FORM 3(8-8-2012).pdf | 2018-08-10 |
| 26 | 1904-MUMNP-2010-GENERAL POWER OF ATTORNEY(3-11-2010).pdf | 2018-08-10 |
| 27 | 1904-MUMNP-2010-Form 3-081015.pdf | 2018-08-10 |
| 27 | 1904-MUMNP-2010-GENERAL POWER OF ATTORNEY(27-4-2015).pdf | 2018-08-10 |
| 28 | 1904-MUMNP-2010-Form 3-160816.pdf | 2018-08-10 |
| 28 | 1904-mumnp-2010-form pct-isa-210.pdf | 2018-08-10 |
| 29 | 1904-MUMNP-2010-Form 3-211217.pdf | 2018-08-10 |
| 29 | 1904-mumnp-2010-form pct-ipea-416.pdf | 2018-08-10 |
| 30 | 1904-mumnp-2010-form 3.pdf | 2018-08-10 |
| 30 | 1904-mumnp-2010-form pct-ipea-409.pdf | 2018-08-10 |
| 31 | 1904-mumnp-2010-form 5.pdf | 2018-08-10 |
| 32 | 1904-mumnp-2010-form 3.pdf | 2018-08-10 |
| 32 | 1904-mumnp-2010-form pct-ipea-409.pdf | 2018-08-10 |
| 33 | 1904-MUMNP-2010-Form 3-211217.pdf | 2018-08-10 |
| 33 | 1904-mumnp-2010-form pct-ipea-416.pdf | 2018-08-10 |
| 34 | 1904-MUMNP-2010-Form 3-160816.pdf | 2018-08-10 |
| 34 | 1904-mumnp-2010-form pct-isa-210.pdf | 2018-08-10 |
| 35 | 1904-MUMNP-2010-Form 3-081015.pdf | 2018-08-10 |
| 35 | 1904-MUMNP-2010-GENERAL POWER OF ATTORNEY(27-4-2015).pdf | 2018-08-10 |
| 36 | 1904-MUMNP-2010-GENERAL POWER OF ATTORNEY(3-11-2010).pdf | 2018-08-10 |
| 36 | 1904-MUMNP-2010-FORM 3(8-8-2012).pdf | 2018-08-10 |
| 37 | 1904-MUMNP-2010-ORIGINAL UNDER RULE 6 (1A)-ASSIGNMENT-041217.pdf | 2018-08-10 |
| 37 | 1904-MUMNP-2010-FORM 3(23-1-2013).pdf | 2018-08-10 |
| 38 | 1904-MUMNP-2010-FORM 3(22-6-2013).pdf | 2018-08-10 |
| 38 | 1904-MUMNP-2010-Original Under Rule 6(1 A)Form 3-250117.pdf | 2018-08-10 |
| 39 | 1904-MUMNP-2010-FORM 3(22-5-2014).pdf | 2018-08-10 |
| 39 | 1904-MUMNP-2010-OTHERS-230215.pdf | 2018-08-10 |
| 40 | 1904-MUMNP-2010-FORM 3(15-2-2012).pdf | 2018-08-10 |
| 40 | 1904-MUMNP-2010-OTHERS-240615.pdf | 2018-08-10 |
| 41 | 1904-MUMNP-2010-FORM 3(15-2-2011).pdf | 2018-08-10 |
| 41 | 1904-mumnp-2010-power of attorney.pdf | 2018-08-10 |
| 42 | 1904-MUMNP-2010-FORM 3(12-8-2011).pdf | 2018-08-10 |
| 42 | 1904-MUMNP-2010-REPLY TO EXAMINATION REPORT(27-4-2015).pdf | 2018-08-10 |
| 43 | 1904-mumnp-2010-form 2.pdf | 2018-08-10 |
| 43 | 1904-mumnp-2010-wo international publication report a2.pdf | 2018-08-10 |
| 44 | 1904-mumnp-2010-form 2(title page).pdf | 2018-08-10 |
| 44 | 1904-mumnp-2010-wo international publication report a3.pdf | 2018-08-10 |
| 45 | 1904-MUMNP-2010-FORM 13(10-2-2012).pdf | 2018-08-10 |
| 45 | 1904-MUMNP-2010_EXAMREPORT.pdf | 2018-08-10 |
| 46 | 1904-MUMNP-2010-PETITION UNDER RULE 137 [27-11-2017(online)].pdf | 2017-11-27 |
| 46 | 1904-mumnp-2010-form 1.pdf | 2018-08-10 |
| 47 | 1904-mumnp-2010-description(complete).pdf | 2018-08-10 |
| 47 | 1904-MUMNP-2010-Proof of Right (MANDATORY) [27-11-2017(online)].pdf | 2017-11-27 |
| 48 | 1904-mumnp-2010-correspondence.pdf | 2018-08-10 |
| 48 | 1904-MUMNP-2010-Response to office action (Mandatory) [06-10-2017(online)].pdf | 2017-10-06 |
| 49 | 1904-MUMNP-2010-Correspondence-240615.pdf | 2018-08-10 |
| 49 | 1904-MUMNP-2010-ORIGINAL UNDER RULE 6(1A)-09-06-2017.pdf | 2017-06-09 |
| 50 | 1904-MUMNP-2010-Correspondence-230215.pdf | 2018-08-10 |
| 50 | Form 13 [05-06-2017(online)].pdf | 2017-06-05 |
| 51 | 1904-MUMNP-2010-Correspondence-121015.pdf | 2018-08-10 |
| 51 | Form 26 [05-06-2017(online)].pdf | 2017-06-05 |
| 52 | 1904-MUMNP-2010-Correspondence-010916.pdf | 2018-08-10 |
| 52 | Other Document [05-06-2017(online)].pdf | 2017-06-05 |
| 53 | 1904-MUMNP-2010-CORRESPONDENCE(31-1-2013).pdf | 2018-08-10 |
| 53 | 1904-MUMNP-2010-FORM 3-(19-03-2016).pdf | 2016-03-19 |
| 54 | 1904-MUMNP-2010-CORRESPONDENCE(18-12-2015).pdf | 2015-12-18 |
| 54 | 1904-MUMNP-2010-CORRESPONDENCE(3-11-2010).pdf | 2018-08-10 |
| 55 | 1904-MUMNP-2010-FORM 3-(25-04-2015).pdf | 2015-04-25 |
| 55 | 1904-mumnp-2010-claims.pdf | 2018-08-10 |
| 56 | 1904-MUMNP-2010-CORRESPONDENCE(IPO)-(FER)-(31-12-2014).pdf | 2014-12-31 |
| 56 | 1904-MUMNP-2010-CLAIMS(AMENDED)-(27-4-2015).pdf | 2018-08-10 |
| 57 | 1904-MUMNP-2010-Form 3-120618.pdf | 2018-09-27 |
| 57 | 1904-MUMNP-2010-FORM 3(10-11-2014).pdf | 2014-11-10 |
| 58 | 1904-MUMNP-2010-FORM 3(10-12-2013).pdf | 2013-12-10 |
| 58 | 1904-MUMNP-2010-AbandonedLetter.pdf | 2018-10-31 |
| 59 | 1904-MUMNP-2010-CORRESPONDENCE(20-12-2011).pdf | 2011-12-20 |
| 59 | 1904-MUMNP-2010-Form 3-301118.pdf | 2019-11-08 |
| 60 | 1904-MUMNP-2010-FORM 18(20-12-2011).pdf | 2011-12-20 |
| 60 | 1904-MUMNP-2010-Form 3-171219.pdf | 2019-12-20 |
| 61 | 1904-MUMNP-2010-CORRESPONDENCE(IPO)-(28-12-2010).pdf | 2010-12-28 |
| 61 | 1904-MUMNP-2010-Form 3-210519.pdf | 2020-01-08 |